Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Organogenesis Holdings Inc. (ORGO)

3.75   -0.09 (-2.34%) 07-01 16:00
Open: 3.84 Pre. Close: 3.84
High: 3.85 Low: 3.75
Volume: 53,585 Market Cap: 398M
Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.859 - 3.878 3.878 - 3.893
Low: 3.698 - 3.723 3.723 - 3.744
Close: 3.714 - 3.753 3.753 - 3.784

Technical analysis

as of: 2020-07-01 4:35:44 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.03     One year: 5.61
Support: Support1: 3.50    Support2: 2.91
Resistance: Resistance1: 4.30    Resistance2: 4.80
Pivot: 3.85
Moving Average: MA(5): 3.82     MA(20): 3.92
MA(100): 3.71     MA(250): 4.91
MACD: MACD(12,26): 0.01     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 46.11     %D(3): 42.05
RSI: RSI(14): 47.19
52-week: High: 8.34  Low: 2.47  Change(%): -52.6
Average Vol(K): 3-Month: 18893  10-Days: 21744

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ORGO has closed above bottom band by 17.6%. Bollinger Bands are 71.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ORGO's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 29 Jun 2020
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020 - GlobeNewswire

Wed, 10 Jun 2020
Organogenesis (NASDAQ:ORGO) Downgraded by Zacks Investment Research to Sell - Stock Market Daily

Fri, 05 Jun 2020
Here is What Hedge Funds Think About Organogenesis Holdings Inc. (ORGO) - Yahoo Finance

Thu, 28 May 2020
Is Organogenesis Holdings Inc (ORGO) Stock a Good Buy on Thursday? - InvestorsObserver

Tue, 12 May 2020
Organogenesis Holdings Inc (ORGO) Q1 2020 Earnings Call Transcript - Motley Fool

Mon, 11 May 2020
Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Drug ManufacturersSpecialty & Generic
Shares Out. (M) 106
Shares Float (M) 12
% Held by Insiders 65.30
% Held by Institutions 27.61
Shares Short (K) 244
Shares Short P. Month (K) 290

Stock Financials

EPS -0.433
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.380
Profit Margin -15.48
Operating Margin -12.21
Return on Assets (ttm) -10.5
Return on Equity (ttm) -112.8
Qtrly Rev. Growth 8.1
Gross Profit (p.s.) 1.744
Sales Per Share 2.503
EBITDA (p.s.) -0.223
Qtrly Earnings Growth
Operating Cash Flow (M) -41
Levered Free Cash Flow (M) -37

Stock Valuations

PE Ratio -8.66
PEG Ratio
Price to Book value 9.87
Price to Sales 1.50
Price to Cash Flow -9.65

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.